Live from the NIH registry
Studies recruiting near Baton Rouge right now
Top 25 of 222 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Pennington Biomedical Research Center /ID# 262390 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50023 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: UCB Biopharma SRL
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Delricht Research — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Incyte Corporation
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Common Warts, Common Warts (Verruca Vulgaris)
Phase 3
Interventional 300 participants sought
DelRicht Research — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Verrica Pharmaceuticals Inc.
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Baton Rouge, LA Investigative Site 10030 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Colorado Prevention Center
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Janssen Research & Development, LLC
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Our Lady of the Lake Regional Medical Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: St. Jude Children's Research Hospital
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AstraZeneca
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Obesity
N/A
Interventional 70 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AdventHealth Translational Research Institute
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Medtronic
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pfizer
R61/33 - VR Study Phase 4
Attention Deficit Hyperactivity Disorder
Phase 4
Interventional 252 participants sought
Louisiana State University — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Rutgers, The State University of New Jersey
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
Phase 3
Interventional 450 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Southern Clinical Research, LLC — Zachary, Louisiana (14.3 mi)
· Sponsor: Pfizer
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Hematology/Oncology Clinic PLLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: SWOG Cancer Research Network
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Novartis Pharmaceuticals
Breath Analysis & Malnutrition
Malnutrition
N/A
Interventional 12 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Louisiana Hematology Oncology Associates LLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: NRG Oncology
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
Baton Rouge General Medical Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: SurModics, Inc.
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 40 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Merus B.V.